What this test measures
HCV quantitative PCR (real-time reverse transcription PCR) measures the actual amount of hepatitis C virus RNA in blood, reported in IU/mL (international units per millilitre). Detection limits are typically 10–15 IU/mL with linear measurement up to 10^7–10^8 IU/mL.
It directly quantifies active infection and is used to confirm hepatitis C, document baseline viral load before treatment, and monitor response. In modern DAA-era HCV care, baseline viral load alone no longer changes drug choice for most patients, but it remains a useful documentation marker.
Why it matters
India has 6–11 million people with chronic HCV. With curative DAA therapy now available — sofosbuvir-based regimens for 8–12 weeks with > 95% cure rates — every patient with a positive anti-HCV needs HCV RNA quantitative testing for confirmation and baseline documentation.
Viral load is also used as a follow-up marker: undetectable HCV RNA at 12 weeks post-treatment defines sustained virological response (SVR) — the cure. NACO India runs the National Viral Hepatitis Control Programme providing free HCV RNA testing and DAA treatment for eligible patients. The test is also essential in HIV co-infection, dialysis populations, and any immunocompromised patient where antibody testing may be unreliable.
How to prepare
No fasting required. The test uses serum or plasma. Bring prior HCV reports (anti-HCV, prior viral loads, genotype if known) for trend interpretation.
Markers & reference ranges
Reference ranges below are typical adult values. Your lab's reported range may differ slightly based on the assay platform and patient demographics — always read your report against the range printed on it.
| Marker | Normal range | If low | If high |
|---|---|---|---|
| HCV RNA Quantitative (IU/mL (log10 IU/mL))[1][2] | Treatment-naïve: any detectable level confirms infection | < 15 IU/mL (undetectable) — no active HCV. In a treated patient at 12 weeks post-treatment, this is SVR (cure). In an untreated patient with positive antibody, indicates spontaneous clearance. | Any detectable level confirms active HCV. Viral load varies widely (10^3–10^7 IU/mL is typical); the absolute number rarely changes DAA drug choice in modern regimens but is documented at baseline. After treatment, any rise from undetectable indicates relapse or re-infection. |
HCV RNA viral load — clinical use
| Scenario | Viral load result | Action |
|---|---|---|
| Baseline before DAA treatment | Documented | Choose pan-genotypic DAA regimen (sofosbuvir + velpatasvir for most) |
| 4 weeks into treatment | Usually undetectable | Continue treatment, check adherence if detectable |
| End of treatment | Undetectable expected | Continue follow-up |
| 12 weeks post-treatment | Undetectable = SVR (cure) | Discharge from HCV follow-up |
| Post-cure rise | Detectable | Relapse or re-infection — re-treat |
| Immunocompromised patient | Direct test | Preferred over antibody testing |
Frequently asked questions
What is the difference between qualitative and quantitative HCV PCR?
Qualitative gives detected/not detected; quantitative gives the actual viral load in IU/mL. Both confirm active infection. Quantitative is preferred for baseline and monitoring.
Does my viral load number determine drug choice?
In modern pan-genotypic DAA therapy (e.g. sofosbuvir + velpatasvir), the absolute viral load rarely changes drug choice. Higher loads or advanced fibrosis sometimes mean longer treatment, decided by your hepatologist.
How fast does HCV viral load drop on treatment?
Most patients become undetectable within 4 weeks of starting DAA therapy. The 12-week post-treatment result defines cure (SVR).
Can HCV viral load fluctuate without treatment?
Yes — natural fluctuations of 0.5–1 log10 IU/mL are normal in chronic HCV. Trend matters more than a single value.
What does SVR mean?
Sustained Virological Response — undetectable HCV RNA 12 weeks after the last dose of antiviral therapy. It is the cure definition; over 95% of treated patients achieve SVR.
After SVR, can HCV come back?
Relapse is rare (< 5%). Re-infection is possible if risk behaviour continues. After SVR, no monitoring is needed unless re-exposure risk exists.
Is HCV genotype also tested?
In the modern pan-genotypic DAA era, genotype is no longer mandatory for most patients. Some labs still report it, but it does not change first-line treatment choice for most.
Related Hepatitis tests
Tests commonly ordered alongside HEPATITIS C VIRUS (HCV) QUANTITATIVE PCR, or that help interpret an unexpected result.
Sources & references
- AASLD-IDSA HCV Guidance · accessed 2026-05-30T00:00:00.000Z
- CDC — Hepatitis C Testing Recommendations · accessed 2026-05-30T00:00:00.000Z
- WHO — Hepatitis C Fact Sheet · accessed 2026-05-30T00:00:00.000Z
- NACO India — National Viral Hepatitis Control Programme · accessed 2026-05-30T00:00:00.000Z
Book with Zelnoo
Get your HEPATITIS C VIRUS (HCV) QUANTITATIVE PCR test done at home — transparent prices, NABL-accredited labs.
Zelnoo lets you compare diagnostic test prices across NABL-accredited labs in Mumbai & Thane, book a free home phlebotomist visit, and receive digital reports in 24–48 hours into a consent-first report vault. No subscriptions, no membership fees — pay only for the test you book.
Book HEPATITIS C VIRUS (HCV) QUANTITATIVE PCR now